SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Barnes, E V
Right arrow Articles by Richards, H B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barnes, E V
Right arrow Articles by Richards, H B
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

High sensitivity C-reactive protein in systemic lupus erythematosus: relation to disease activity, clinical presentation and implications for cardiovascular risk

E V Barnes

Department of Medicine, Division of Rheumatology & Clinical Immunology, University of Florida, Gainesville, FL 32610-0221, USA

S Narain

Department of Medicine, Division of Rheumatology & Clinical Immunology, University of Florida, Gainesville, FL 32610-0221, USA

A Naranjo

Department of Biostatistics, University of Florida, Gainesville, FL 32610-0221, USA

J Shuster

Department of Biostatistics, University of Florida, Gainesville, FL 32610-0221, USA

M S Segal

Nephrology, Hypertension and Transplantation, University of Florida, Gainesville, FL 32610-0221, USA

E S Sobel

Department of Medicine, Division of Rheumatology & Clinical Immunology, University of Florida, Gainesville, FL 32610-0221, USA

A E Armstrong

Department of Medicine, Division of Rheumatology & Clinical Immunology, University of Florida, Gainesville, FL 32610-0221, USA

B E Santiago

Department of Medicine, Division of Rheumatology & Clinical Immunology, University of Florida, Gainesville, FL 32610-0221, USA

W H Reeves

Department of Medicine, Division of Rheumatology & Clinical Immunology, University of Florida, Gainesville, FL 32610-0221, USA

H B Richards

Department of Medicine, Division of Rheumatology & Clinical Immunology, University of Florida, Gainesville, FL 32610-0221, USA, richahb{at}medicine.ufl.edu

Measurement of high sensitivity C-reactive protein (hs-CRP), has been used in the assessment of disease activity in numerous rheumatic conditions including systemic lupus erythematosus (SLE). However, the utility of hs-CRP measurement in patients with lupus is uncertain. This study examined if hs-CRP can be used to assess disease activity, severity and cardiovascular risk in SLE. Serum samples from 601 visits of 213 SLE patients and 134 controls were analysed for hs-CRP by nephelometry. Detailed demographic data were obtained from all subjects and medication history and key laboratory parameters were collected. Disease activity was assessed using the SLEDAI. High sensitivity CRP was not associated with disease activity (SLEDAI), number of ACR SLE criteria or presence of any particular organ involvement. hs-CRP levels were significantly correlated with standard cardiovascular risk factors including body weight (P = 0.0002), hypertension (P = 0.001), and apolipoprotein A-I (P < 0.0001). Interestingly an inverse correlation was seen between hs-CRP levels and antimalarial use (P = 0.0018). Our results suggest that measurement of hs-CRP, though not valuable as marker of disease activity in SLE may be of some use in the assessment of cardiovascular risk. We speculate that antimalarials may help to reduce cardiovascular risk in patients with SLE.

Key Words: C-reactive protein • hs-CRP • SLE

Lupus, Vol. 14, No. 8, 576-582 (2005)
DOI: 10.1191/0961203305lu2157oa


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
LupusHome page
T Sugiura, Y Kumon, H Kataoka, Y Matsumura, H Takeuchi, and Y. Doi
Asymptomatic pericardial effusion in patients with systemic lupus erythematosus
Lupus, February 1, 2009; 18(2): 128 - 132.
[Abstract] [PDF]


Home page
LupusHome page
S-S. Lee, S. Singh, L. Magder, and M. Petri
Predictors of high sensitivity C-reactive protein levels in patients with systemic lupus erythematosus
Lupus, February 1, 2008; 17(2): 114 - 123.
[Abstract] [PDF]


Home page
LupusHome page
F. Burling, J. Ng, H. Thein, J. Ly, M.R. Marshall, and P. Gow
Ethnic, clinical and immunological factors in systemic lupus erythematosus and the development of lupus nephritis: results from a multi-ethnic New Zealand cohort
Lupus, October 1, 2007; 16(10): 830 - 837.
[Abstract] [PDF]


Home page
LupusHome page
Z Szekanecz and Y Shoenfeld
Lupus and cardiovascular disease: the facts
Lupus, November 1, 2006; 15(11_suppl): 3 - 10.
[Abstract] [PDF]


Home page
LupusHome page
N Bjarnegard, C Bengtsson, J Brodszki, G Sturfelt, O Nived, and T Lanne
Increased aortic pulse wave velocity in middle aged women with systemic lupus erythematosus
Lupus, October 1, 2006; 15(10): 644 - 650.
[Abstract] [PDF]



Advertisement